DRUGS & SUPPLEMENTS

Sumamed

Rating: 3.8 - 17 review(s)
advertisement

Sumamed uses


1 INDICATIONS AND USAGE

Sumamed® is indicated for the treatment of bacterial conjunctivitis caused by susceptible isolates of the following microorganisms:

  • CDC coryneform group G*
  • Haemophilus influenzae
  • Staphylococcus aureus
  • Streptococcus mitis group
  • Streptococcus pneumoniae
  • * Efficacy for this organism was studied in fewer than 10 infections.

Sumamed is a macrolide antibiotic indicated for the treatment of bacterial conjunctivitis caused by susceptible isolates of the following microorganisms: CDC coryneform group G, Haemophilus influenzae, Staphylococcus aureus, Streptococcus mitis group, and Streptococcus pneumoniae. (1)

2 DOSAGE AND ADMINISTRATION

The recommended dosage regimen for the treatment of bacterial conjunctivitis is:

Instill 1 drop in the affected eye(s) twice daily, eight to twelve hours apart for the first two days and then instill 1 drop in the affected eye(s) once daily for the next five days.

Instill 1 drop in the affected eye(s) twice daily, eight to twelve hours apart for the first two days and then instill 1 drop in the affected eye(s) once daily for the next five days. (2)

advertisement

3 DOSAGE FORMS AND STRENGTHS

2.5 mL of a 1% sterile topical ophthalmic solution.

2.5 mL of 1% sterile topical ophthalmic solution. (3)

4 CONTRAINDICATIONS

Hypersensitivity to any component of this product.

Hypersensitivity (4)

5 WARNINGS AND PRECAUTIONS

  • For topical ophthalmic use only.
  • Anaphylaxis and hypersensitivity have been reported with systemic use of Sumamed. (5.2)
  • Growth of resistant organisms may occur with prolonged use. (5.3)
  • Patients should not wear contact lenses if they have signs or symptoms of bacterial conjunctivitis. (5.4)

5.1 Topical Ophthalmic Use Only

NOT FOR INJECTION. Sumamed is indicated for topical ophthalmic use only, and should not be administered systemically, injected subconjunctivally, or introduced directly into the anterior chamber of the eye.

5.2 Anaphylaxis and Hypersensitivity with Systemic Use of Sumamed

In patients receiving systemically administered Sumamed, serious allergic reactions, including angioedema, anaphylaxis, and dermatologic reactions including Stevens-Johnson syndrome and toxic epidermal necrolysis have been reported rarely in patients on Sumamed therapy. Although rare, fatalities have been reported. The potential for anaphylaxis or other hypersensitivity reactions should be considered based on known hypersensitivity to Sumamed when administered systemically.

5.3 Growth of Resistant Organisms with Prolonged Use

As with other anti-infectives, prolonged use may result in overgrowth of non-susceptible organisms, including fungi. If super-infection occurs, discontinue use and institute alternative therapy. Whenever clinical judgment dictates, the patient should be examined with the aid of magnification, such as slit-lamp biomicroscopy, and where appropriate, fluorescein staining.

5.4 Avoidance of Contact Lenses

Patients should be advised not to wear contact lenses if they have signs or symptoms of bacterial conjunctivitis.

advertisement

6 ADVERSE REACTIONS

Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in one clinical trial of a drug cannot be directly compared with the rates in the clinical trials of the same or another drug and may not reflect the rates observed in practice.

The data described below reflect exposure to Sumamed in 698 patients. The population was between 1 and 87 years old with clinical signs and symptoms of bacterial conjunctivitis. The most frequently reported ocular adverse reaction reported in patients receiving Sumamed was eye irritation. This reaction occurred in approximately 1-2% of patients. Other adverse reactions associated with the use of Sumamed were reported in less than 1% of patients and included ocular reactions (blurred vision, burning, stinging and irritation upon instillation, contact dermatitis, corneal erosion, dry eye, eye pain, itching, ocular discharge, punctate keratitis, visual acuity reduction) and non-ocular reactions (dysgeusia, facial swelling, hives, nasal congestion, periocular swelling, rash, sinusitis, urticaria).

Most common adverse reaction reported in patients was eye irritation (1-2% of patients). (6)

To report SUSPECTED ADVERSE REACTIONS, contact Akorn, Inc. at 1-800-932-5676 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch .

8 USE IN SPECIFIC POPULATIONS

8.1 Pregnancy

Pregnancy Category B. Reproduction studies have been performed in rats and mice at doses up to 200 mg/kg/day. The highest dose was associated with moderate maternal toxicity. These doses are estimated to be approximately 5,000 times the maximum human ocular daily dose of 2 mg. In the animal studies, no evidence of harm to the fetus due to Sumamed was found. There are, however, no adequate and well-controlled studies in pregnant women. Because animal reproduction studies are not always predictive of human response, Sumamed should be used during pregnancy only if clearly needed.

8.3 Nursing Mothers

It is not known whether Sumamed is excreted in human milk. Because many drugs are excreted in human milk, caution should be exercised when Sumamed is administered to a nursing woman.

8.4 Pediatric Use

The safety and effectiveness of Sumamed solution in pediatric patients below 1 year of age have not been established. The efficacy of Sumamed in treating bacterial conjunctivitis in pediatric patients one year or older has been demonstrated in controlled clinical trials .

8.5 Geriatric Use

No overall differences in safety or effectiveness have been observed between elderly and younger patients.

advertisement

11 DESCRIPTION

Sumamed (azithromycin ophthalmic solution) is a 1% sterile aqueous topical ophthalmic solution of Sumamed formulated in DuraSite® (polycarbophil, edetate disodium, sodium chloride). Sumamed is an off-white, viscous liquid with an osmolality of approximately 290 mOsm/kg.

Preservative: 0.003% benzalkonium chloride. Inactives: mannitol, citric acid, sodium citrate, poloxamer 407, polycarbophil, edetate disodium (EDTA), sodium chloride, water for injection, and sodium hydroxide to adjust pH to 6.3.

Sumamed is a macrolide antibiotic with a 15-membered ring. Its chemical name is (2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-13-[(2,6-dideoxy-3-C-methyl-3-O-methyl-α-L-ribohexopyranosyl)oxy]-2-ethyl-3,4,10-trihydroxy-3,5,6,8,10,12,14-heptamethyl-11-[[3,4,6-trideoxy-3-(dimethylamino)-β-D-xylo-hexopyranosyl]oxy]1-oxa-6-aza-cyclopentadecan-15-one, and the structural formula is:

Sumamed has a molecular weight of 749, and its empirical formula is C38H72N2O12.

Structural Formula

12 CLINICAL PHARMACOLOGY

12.1 Mechanism of Action

Sumamed is a macrolide antibiotic .

12.3 Pharmacokinetics

The plasma concentration of Sumamed following ocular administration of Sumamed (azithromycin ophthalmic solution) in humans is unknown. Based on the proposed dose of one drop to each eye (total dose of 100 mcL or 1 mg) and exposure information from systemic administration, the systemic concentration of Sumamed following ocular administration is estimated to be below quantifiable limits (≤10 ng/mL) at steady-state in humans, assuming 100% systemic availability.

12.4 Microbiology

Sumamed acts by binding to the 50S ribosomal subunit of susceptible microorganisms and interfering with microbial protein synthesis.

Sumamed has been shown to be active against most isolates of the following microorganisms, both in vitro and clinically in conjunctival infections .

  • CDC coryneform group G*
  • Haemophilus influenzae
  • Staphylococcus aureus
  • Streptococcus mitis group
  • Streptococcus pneumoniae
  • * Efficacy for this organism was studied in fewer than 10 infections.

The following in vitro data are also available, but their clinical significance in ophthalmic infections is unknown. The safety and effectiveness of Sumamed in treating ophthalmological infections due to these microorganisms have not been established.

The following microorganisms are considered susceptible when evaluated using systemic break points. However, a correlation between the in vitro systemic breakpoint and ophthalmological efficacy has not been established. This list of microorganisms is provided as an aid only in assessing the potential treatment of conjunctival infections. Sumamed exhibits in vitro minimal inhibitory concentrations (MICs) of equal or less (systemic susceptible breakpoint) against most (≥90%) of isolates of the following ocular pathogens:

  • Chlamydia pneumoniae
  • Chlamydia trachomatis
  • Legionella pneumophila
  • Moraxella catarrhalis
  • Mycoplasma hominis
  • Mycoplasma pneumoniae
  • Neisseria gonorrhoeae
  • Peptostreptococcus species
  • Streptococci (Groups C, F, G)
  • Streptococcus pyogenes
  • Streptococcus agalactiae
  • Ureaplasma urealyticum
  • Viridans group streptococci
advertisement

13 NONCLINICAL TOXICOLOGY

13.1 Carcinogenesis, Mutagenesis, Impairment of Fertility

Long-term studies in animals have not been performed to evaluate carcinogenic potential. Sumamed has shown no mutagenic potential in standard laboratory tests: mouse lymphoma assay, human lymphocyte clastogenic assay, and mouse bone marrow clastogenic assay. No evidence of impaired fertility due to Sumamed was found in mice or rats that received oral doses of up to 200 mg/kg/day.

13.2 Animal Toxicology and/or Pharmacology

Phospholipidosis (intracellular phospholipid accumulation) has been observed in some tissues of mice, rats, and dogs given multiple systemic doses of Sumamed. Cytoplasmic microvacuolation, which is likely a manifestation of phospholipidosis, has been observed in the corneas of rabbits given multiple ocular doses of Sumamed. This effect was reversible upon cessation of Sumamed treatment. The significance of this toxicological finding for animals and for humans is unknown.

14 CLINICAL STUDIES

In a randomized, vehicle-controlled, double-blind, multicenter clinical study in which patients were dosed twice daily for the first two days, then once daily on days 3, 4, and 5, Sumamed solution was superior to vehicle on days 6-7 in patients who had a confirmed clinical diagnosis of bacterial conjunctivitis. Clinical resolution was achieved in 63% (82/130) of patients treated with Sumamed versus 50% (74/149) of patients treated with vehicle. The p-value for the comparison was 0.03 and the 95% confidence interval around the 13% (63%-50%) difference was 2% to 25%. The microbiological success rate for the eradication of the baseline pathogens was approximately 88% compared to 66% of patients treated with vehicle (p<0.001, confidence interval around the 22% difference was 13% to 31%). Microbiologic eradication does not always correlate with clinical outcome in anti-infective trials.

16 HOW SUPPLIED/STORAGE AND HANDLING

Sumamed is a sterile aqueous topical ophthalmic formulation of 1% Sumamed.

NDC 17478-307-03: 2.5 mL in 5 mL bottle containing a total of 25 mg of Sumamed in a white, round, low-density polyethylene (LDPE) bottle, with a clear LDPE dropper tip, and a tan colored high density polyethylene (HDPE) eyedropper cap. A white tamper evident over-cap is provided.

NDC 17478-307-04: 2.5 mL in 4 mL bottle containing a total of 25 mg of Sumamed in a white, round, low-density polyethylene (LDPE) bottle, with a clear LDPE dropper tip, and a tan colored high density polyethylene (HDPE) eyedropper cap. A white tamper evident over-cap is provided.

Storage and Handling:

Store unopened bottle under refrigeration at 2°C to 8°C (36°F to 46°F). Once the bottle is opened, store at 2°C to 25°C (36°F to 77°F) for up to 14 days. Discard after the 14 days.

17 PATIENT COUNSELING INFORMATION

See FDA-Approved Patient Labeling (Patient Information).

Patients should be advised to avoid contaminating the applicator tip by allowing it to touch the eye, fingers or other sources.

Patients should be directed to discontinue use and contact a physician if any signs of an allergic reaction occur.

Patients should be told that although it is common to feel better early in the course of the therapy, the medication should be taken exactly as directed. Skipping doses or not completing the full course of therapy may (1) decrease the effectiveness of the immediate treatment and (2) increase the likelihood that bacteria will develop resistance and will not be treatable by Sumamed (azithromycin ophthalmic solution) or other antibacterial drugs in the future.

Patients should be advised not to wear contact lenses if they have signs or symptoms of bacterial conjunctivitis.

Patients should be advised to thoroughly wash hands prior to using Sumamed.

Patients should be advised to invert the closed bottle (upside down) and shake once before each use. Remove cap with bottle still in the inverted position. Tilt head back, and with bottle inverted, gently squeeze bottle to instill one drop into the affected eye(s).

AKORN

Distributed by: Akorn, Inc.

Lake Forest, IL 60045

U.S. Patent Nos.: 6,159,458; 6,239,113; 6,569,443; 6,861,411; 7,056,893; and Patents Pending

Sumamed is a registered trademark of InSite Vision Inc.

OPZT00N      Rev. 11/13

PATIENT INFORMATION

Sumamed ® (A-zuh-site)

(azithromycin ophthalmic solution) 1%

Read this Patient Information before you start using Sumamed® and each time you get a refill. There may be new information. This information does not take the place of talking to your doctor about your medical condition or treatment.

What is Sumamed?

Sumamed is a prescription sterile eye drop solution. Sumamed is used to treat bacterial conjunctivitis which is an infection of the eye caused by certain bacteria.

It is not known if Sumamed is safe and effective in children less than 1 year of age.

Information about bacterial conjunctivitis.

Bacterial conjunctivitis is a bacterial infection of the mucous membranes which line the inside of the eyelids. Symptoms may include redness of the eye and discharge. The infection can be spread to other people and to both eyes.

Who should not use Sumamed?

Do not use Sumamed if you are allergic to Sumamed or any of the ingredients in Sumamed. See the end of this Patient Information leaflet for a complete list of the ingredients in Sumamed.

What should I tell my doctor before using Sumamed?

Before you use Sumamed, tell your doctor if you:

  • wear contact lenses. Do not wear contact lenses if you have signs or symptoms of bacterial conjunctivitis.
  • are pregnant or plan to become pregnant. It is not known if Sumamed will harm your unborn baby. Talk to your doctor if you are pregnant or plan to become pregnant.
  • are breast-feeding or plan to breast-feed. It is not known if Sumamed passes into your breast milk. Talk to your doctor about the best way to feed your baby if you are using Sumamed.

Tell your doctor about all the medicines you take, including prescription and non-prescription medicines, vitamins, and herbal supplements.

Know the medicines you take. Keep a list of them to show your doctors and pharmacist when you get a new medicine.

How should I use Sumamed?

  • Read the Instructions for Use at the end of this Patient Information leaflet for the right way to use Sumamed.
  • Use Sumamed exactly as your doctor tells you to use it.
  • For the first 2 days place 1 drop of Sumamed in your eye (or eyes) each morning and 1 drop in your eye (or eyes) each evening. Wait 8 to 12 hours after placing your morning drops before you place evening drops in your eye (or eyes).
  • For the next 5 days place 1 drop of Sumamed in your eye (or eyes) 1 time each day.
  • Make sure you continue to use Sumamed as directed by your doctor even if you feel better after you start using it. Skipping drops can increase the chances that:
    • your medicine will not work well
    • Bacteria can develop resistance, which means in the future your bacterial conjunctivitis may not improve from Sumamed or other drugs that treat infections from bacteria.

What should I be aware of while using Sumamed?

Do not wear contact lenses if you have signs or symptoms of bacterial conjunctivitis and until you have finished your prescribed course of treatment. The symptoms of bacterial conjunctivitis may include:

  • discharge coming from the eye
  • eye redness
  • eye irritation

Only your doctor can tell you if you have bacterial conjunctivitis.

Severe allergic reactions have been reported rarely when Sumamed has been taken by mouth.

  • Serious rash or serious allergic reactions may occur. Sumamed, the active ingredient in Sumamed, may cause a serious rash or a serious allergic reaction. Both of these reactions may need to be treated in a hospital and may be life-threatening.
  • Stop taking Sumamed and call your doctor right away or get emergency help if you have any of these symptoms:
    • skin rash, hives, sores in your mouth, or your skin blisters and peels
    • swelling of your face, eyes, lips, tongue, or throat
    • trouble swallowing or breathing

Increased risk of other infections caused by bacteria or fungi.

  • Using Sumamed for a long time may cause other bacteria or fungi to grow. If this happens you may get a new infection. Tell your doctor right away if your symptoms do not get better.

What are the possible side effects of Sumamed?

The most common side effect of Sumamed is eye irritation.

Other side effects seen with Sumamed include:

  • eye burning, stinging and irritation when the drop hits your eye
  • irritation on your eyelid and the skin around your eye
  • a feeling of discomfort and irritation or that something is in your eye
  • dry eye
  • eye pain
  • eye itching
  • discharge coming from your eye
  • changes to the surface of your eye
  • blurred vision
  • changes in your taste
  • hives and rash on your skin
  • stuffy nose and sinus infection
  • swelling around your eye or of your face

Tell your doctor about any side effect that bothers you or that does not go away.

These are not all of the possible side effects of Sumamed. For more information, ask your doctor or pharmacist.

Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

How should I store Sumamed?

  • Before you open your Sumamed, store it in the refrigerator between 36°F to 46°F (2°C to 8°C).
  • After you open your Sumamed, store it at room temperature or the refrigerator between 36°F to 77°F (2°C to 25°C).
  • Sumamed should not be stored for more than 14 days after opening. After 14 days, throw the Sumamed bottle away.
  • Safely throw away medicine that is out of date or no longer needed.

Keep Sumamed and all medicines out of reach of children.

General information about the safe and effective use of Sumamed

Medicines are sometimes prescribed for purposes other than those listed in a Patient Information leaflet. Do not use Sumamed for a condition for which it was not prescribed. Do not give Sumamed to other people, even if they have the same symptoms that you have. It may harm them.

This Patient Information summarizes the most important information about Sumamed. If you would like more information, talk with your doctor. You can ask your pharmacist or doctor for information about Sumamed that is written for health professionals.

For more information, go to www.azasite.com or call 1-800-932-5676.

What are the ingredients in Sumamed?

Active ingredient: Sumamed

Inactive ingredients: 0.003% benzalkonium chloride, mannitol, citric acid, sodium citrate, poloxamer 407, polycarbophil, edetate disodium (EDTA), sodium chloride, water, and sodium hydroxide.

Instructions for Use

Sumamed ® (A-zuh-site)

(azithromycin ophthalmic solution) 1%

Read this Instructions for Use for Sumamed before you start using it and each time you get a refill. There may be new information. This leaflet does not take the place of talking to your doctor about your medical condition or treatment.

Important:

  • Sumamed is for use as an eye drop only.

The checklist below tells you when to use your medicine for each eye that has bacterial conjunctivitis:

This is a total of 9 drops of Sumamed for each infected eye.

  • Avoid letting the applicator tip touch your eye, your fingers, or other objects.
  • If a drop misses your eye, try again.
  • Follow the steps below to use Sumamed correctly.

Before using a new bottle of Sumamed:

  • Turn the white cap clockwise until it comes off. Throw away the white cap. See Figure A
  • Hold the bottle straight, turn the tan cap counterclockwise until it comes off. Put the tan cap back on the bottle and close tightly. (This lets out the air.) See Figure B

Wash your hands each time you use Sumamed.

To use Sumamed:

Step 1. Turn the closed bottle upside down. See Figure C

Step 2. Shake your hand firmly. This helps move the medicine into the tip of the bottle. See Figure D

Step 3. Hold the bottle upside down and take off the tan cap. See Figure E

Step 4. Tilt your head back. Hold the bottle over your eye and gently squeeze the bottle to let 1 drop into each eye that has bacterial conjunctivitis. Put the tan cap back on the bottle and close tightly. See Figure F

If a drop does not come out of the bottle, repeat steps one to four.

This Patient Information and Instructions for Use have been approved by the U.S. Food and Drug Administration.

AKORN

Distributed by: Akorn, Inc.

Lake Forest, IL 60045

U.S. Patent Nos.: 6,159,458; 6,239,113; 6,569,443; 6,861,411; 7,056,893; and Patents Pending

Sumamed is a registered trademark of InSite Vision Inc.

OPZTA0N Rev. 02/15

Checklist Figure A Figure B Figure C Figure D Figure E Figure F

Principal Display Panel Text for Container Label:

NDC 17478-307-03

Sumamed®

(azithromycin ophthalmic solution) 1%

Rx Only Sterile 2.5 mL

Principal Display Panel Text for Carton Label:

NDC 17478-307-03

Sumamed®

(azithromycin ophthalmic solution) 1%

Sterile 2.5 mL

Rx Only

FOR OPHTHALMIC USE ONLY

Sumamed pharmaceutical active ingredients containing related brand and generic drugs:

infoActive ingredient is the part of the drug or medicine which is biologically active. This portion of the drug is responsible for the main action of the drug which is intended to cure or reduce the symptom or disease. The other portions of the drug which are inactive are called excipients; there role is to act as vehicle or binder. In contrast to active ingredient, the inactive ingredient's role is not significant in the cure or treatment of the disease. There can be one or more active ingredients in a drug.


Sumamed available forms, composition, doses:

infoForm of the medicine is the form in which the medicine is marketed in the market, for example, a medicine X can be in the form of capsule or the form of chewable tablet or the form of tablet. Sometimes same medicine can be available as injection form. Each medicine cannot be in all forms but can be marketed in 1, 2, or 3 forms which the pharmaceutical company decided based on various background research results.
Composition is the list of ingredients which combinedly form a medicine. Both active ingredients and inactive ingredients form the composition. The active ingredient gives the desired therapeutic effect whereas the inactive ingredient helps in making the medicine stable.
Doses are various strengths of the medicine like 10mg, 20mg, 30mg and so on. Each medicine comes in various doses which is decided by the manufacturer, that is, pharmaceutical company. The dose is decided on the severity of the symptom or disease.


Sumamed destination | category:

infoDestination is defined as the organism to which the drug or medicine is targeted. For most of the drugs what we discuss, human is the drug destination.
Drug category can be defined as major classification of the drug. For example, an antihistaminic or an antipyretic or anti anginal or pain killer, anti-inflammatory or so.


Sumamed Anatomical Therapeutic Chemical codes:

infoA medicine is classified depending on the organ or system it acts [Anatomical], based on what result it gives on what disease, symptom [Therapeutical], based on chemical composition [Chemical]. It is called as ATC code. The code is based on Active ingredients of the medicine. A medicine can have different codes as sometimes it acts on different organs for different indications. Same way, different brands with same active ingredients and same indications can have same ATC code.


Sumamed pharmaceutical companies:

infoPharmaceutical companies are drug manufacturing companies that help in complete development of the drug from the background research to formation, clinical trials, release of the drug into the market and marketing of the drug.
Researchers are the persons who are responsible for the scientific research and is responsible for all the background clinical trials that resulted in the development of the drug.


advertisement

References

  1. Dailymed."ZITHROMAX (AZITHROMYCIN DIHYDRATE) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [PFIZER LABORATORIES DIV PFIZER INC]". https://dailymed.nlm.nih.gov/dailymed/dr... (accessed May 21, 2018).

Frequently asked Questions

Can i drive or operate heavy machine after consuming Sumamed?

Depending on the reaction of the Sumamed after taken, if you are feeling dizziness, drowsiness or any weakness as a reaction on your body, Then consider Sumamed not safe to drive or operate heavy machine after consumption. Meaning that, do not drive or operate heavy duty machines after taking the capsule if the capsule has a strange reaction on your body like dizziness, drowsiness. As prescribed by a pharmacist, it is dangerous to take alcohol while taking medicines as it exposed patients to drowsiness and health risk. Please take note of such effect most especially when taking Primosa capsule. It's advisable to consult your doctor on time for a proper recommendation and medical consultations.

Is Sumamed addictive or habit forming?

Medicines are not designed with the mind of creating an addiction or abuse on the health of the users. Addictive Medicine is categorically called Controlled substances by the government. For instance, Schedule H or X in India and schedule II-V in the US are controlled substances.

Please consult the medicine instruction manual on how to use and ensure it is not a controlled substance.In conclusion, self medication is a killer to your health. Consult your doctor for a proper prescription, recommendation, and guidiance.

advertisement

Review

sDrugs.com conducted a study on Sumamed, and the result of the survey is set out below. It is noteworthy that the product of the survey is based on the perception and impressions of the visitors of the website as well as the views of Sumamed consumers. We, as a result of this, advice that you do not base your therapeutic or medical decisions on this result, but rather consult your certified medical experts for their recommendations.

Visitor reports

Six visitors reported useful

How is the drug Sumamed useful in reducing or relieving the symptoms? How useful is it?
According to the survey conducted by the website sDrugs.com, there are variable results and below are the percentages of the users that say the medicine is useful to them and that say it is not helping them much. It is not ideal to continue taking the medication if you feel it is not helping you much. Contact your healthcare provider to check if there is a need to change the medicine or if there is a need to re-evaluate your condition. The usefulness of the medicine may vary from patient to patient, depending on the other diseases he is suffering from and slightly depends on the brand name.
Visitors%
Useful6
100.0%

Six visitors reported side effects

Did you get side effects while taking the Sumamed drug, or were there no side effects?
According to the survey conducted by website sDrugs.com users, the below-mentioned percentages indicate the number of people experiencing the side effects and the number of people not experiencing the side effects when taking Sumamed medicine. Every drug produces minimal side effects, and they are negligible most times, when compared to the desired effect [use] of the medicine. Side effects depend on the dose you are taking, any drug interactions that happen when you are on other medications, if the patient is sensitive, and other associated conditions. If you cannot tolerate the side effects, consult your doctor immediately, so he can either adjust the dose or change the medication.
Visitors%
It has side effects4
66.7%
No side effects2
33.3%

Five visitors reported price estimates

What is your opinion about drug cost? Did you feel the cost is apt, or did you feel it is expensive?
The report given by the sDrugs.com website users shows the following figures about several people who felt the medicine Sumamed is expensive, and the medicine is not expensive. The results are mixed. The perception of the cost of the medicine to be expensive or not depends on the brand name of the medicine, country, and place where it is sold, and the affordability of the patient. You can choose a generic drug in the place of the branded drug to save the cost. The efficiency of the medicine will not vary if it is generic or a branded one.
Visitors%
Not expensive5
100.0%

Four visitors reported frequency of use

How often in a day do you take the medicine?
Are you taking the Sumamed drug as prescribed by the doctor?

Few medications can be taken Once in a day more than prescribed when the doctor's advice mentions the medicine can be taken according to frequency or severity of symptoms. Most times, be very careful and clear about the number of times you are taking the medication. The report of sDrugs.com website users about the frequency of taking the drug Sumamed is mentioned below.
Visitors%
Once in a day4
100.0%

Five visitors reported doses

What is the dose of Sumamed drug you are taking?
According to the survey conducted among sDrugs.com website users, the maximum number of people are using the following dose 201-500mg. Few medications come in only one or two doses. Few are specific for adult dose and child dose. The dose of the medicine given to the patient depends on the severity of the symptom/disease. There can be dose adjustments made by the doctor, based on the progression of the disease. Follow-up is important.
Visitors%
201-500mg5
100.0%

Five visitors reported time for results

What is the time duration Sumamed drug must be taken for it to be effective or for it to reduce the symptoms?
Most chronic conditions need at least some time so the dose and the drug action gets adjusted to the body to get the desired effect. The stastistics say sDrugs.com website users needed 3 days to notice the result from using Sumamed drug. The time needed to show improvement in health condition after using the medicine Sumamed need not be same for all the users. It varies based on other factors.
Visitors%
3 days5
100.0%

Four visitors reported administration

The drugs are administered in various routes, like oral or injection form. They are administered before food or after food. How are you taking Sumamed drug, before food or after food?
Click here to find out how other users of our website are taking it. For any doubts or queries on how and when the medicine is administered, contact your health care provider immediately.
Visitors%
Before food2
50.0%
Empty stomach2
50.0%

Four visitors reported age

Visitors%
46-603
75.0%
< 11
25.0%

Visitor reviews


There are no reviews yet. Be the first to write one!


Your name: 
Email: 
Spam protection:  < Type 19 here

The information was verified by Dr. Arunabha Ray, MD Pharmacology

© 2002 - 2018 "sDrugs.com". All Rights Reserved